Besides, CTCF (CCCTC-binding factor) was validated to activate HOXA11-AS transcription in prostate cancer cells and consequently to facilitate cell proliferation and migration by targeting miR-518b/ACTN4 [36]. This evidence concerns the gene ACTN4 and prostate carcinoma.